Tumor vaccine-induced specific T-cell injection

DRUG2 trials

Sponsors

Jia Wei, Beijing GoBroad Hospital

Conditions

Advanced Gastric CancerGastrointestinal Cancer

Phase 1

Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer

RecruitingNCT07298200

Jia WeiAdvanced Gastric Cancer

Start: 2025-12-26End: 2029-11-01Target: 18Updated: 2026-02-25

Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastrointestinal Cancer

RecruitingNCT07329894

Beijing GoBroad HospitalGastrointestinal Cancer

Start: 2026-02-01End: 2029-10-01Target: 18Updated: 2026-02-12